Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — 4QFY17 Earnings Presentation
20 slides from Sunshine's earnings presentation, May 31, 2017
Slide 1: Sunshine
IN Sunshine
Slide 2: Earnings Presentation 4QFY17
Earnings Presentation 4QFY17 31th May 2017
Slide 3: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 4: Group Performance
Group Performance
Slide 5: Group at a Glance – FY17 [Apr–Mar]
Group at a Glance – FY17 [Apr–Mar] • LKR 19.2bn in Revenue; +10.3% YoY • LKR 1.6bn PAT; +33.1% YoY • PATMI of LKR 572m; -2.5% YoY Revenue- FY17 • Healthcare revenue; LKR 7.9bn; +9.8% YoY Other, 3.3% • Agri revenue; LKR 6.5bn; +3.2% YoY. FMCG, 21.9% Health 10.6m kg of palm oil, +18.2% YoY. care, LK
Slide 6: Group at a Glance – 4QFY17 [Jan-Mar]
Group at a Glance – 4QFY17 [Jan-Mar] • LKR 5.1bn in Revenue; +10.8% YoY • LKR 283m PAT; +68.0% YoY • PATMI of LKR 1256m; +61.1% YoY Revenue- 4QFY17 • Healthcare revenue; LKR 2.0bn; +7.7% YoY Other, FMCG, 2.2% • Agri revenue; LKR 1.8bn; +4.8% YoY. 23.5% Health care, 2.2m kg of palm oil, +14.6% YoY.
Slide 7: Group Financial Highlights
Group Financial Highlights Growth 4Q 4Q Growth LKRm FY17 FY16 % FY17 FY16 % Revenue 19,217 17,422 10.3 5,115 4,615 10.8 EBIT 2,098 1,661 26.3 433 273 58.9 EBIT Margin 10.9% 9.5% 8.5% 5.9% Profit for the period 1,621 1,218 33.1 283 169 68.0 PAT Margin 8.4% 7.0% 5.5% 3.7% Normalized PAT* 1,816 1,218 4
Slide 8: 4Q Revenue Growth Trend
4Q Revenue Growth Trend • 5 Year CAGR of 12% 5 Yr CAGR: 12% Revenue growth 5 ,5 00 22% 5,115 25% 5 ,0 00 20% 4,615 4 ,5 00 3,982 4,105 20% 12% 4 ,0 00 3,274 LKR m 11% 15% 3 ,5 00 3 ,0 00 10% Revenue Growth % 2 ,5 00 2 ,0 00 3% 5% 1 ,5 00 1 ,0 00 0% 4QFY13 4QFY14 4QFY15 4QFY16 4QFY17
Slide 9: 4Q Profitability
4Q Profitability PAT Margins 4 00 8.8% 10% 3 50 7.5% 9% 8% 5.5% 3 00 5.0% 7% LKR m 2 50 6% 2 00 3.7% 5% 4% PAT 1 50 PAT margin % 246 350 207 169 283 3% 1 00 2% 50 1% - 0% 4QFY13 4QFY14 4QFY15 4QFY16 4QFY17 • Profits grew despite challenging externalities • Healthcare margins affected by price contro
Slide 10: Earnings Contribution
Earnings Contribution PAT- 4QFY17 PAT- 4QFY17 Other, - Other, - 21.9% Healthca 22.9% re, 37.8% FMCG, FMCG, 9.3% 6.3% Healthcare, LKR 283m LKR 126m 77.9% Agri, 38.6% Agri, 74.8% • Lower impact of Agri sector at PATMI level. Effecting holding is 25%. *Other includes= Packaging + Power + Inter company
Slide 11: Segment Performance 4Q FY17
Segment Performance 4Q FY17
Slide 12: Healthcare
Healthcare Growth 4Q 4Q Growth LKRm FY17 FY16 % FY17 FY16 % Revenue 7,863 7,161 9.8 2,037 1,891 7.7 EBIT 343 514 (33.2) 151 114 31.8 EBIT Margin 4.4% 7.2% 7.4% 6.1% PAT 198 327 (39.6) 107 63 69.3 PAT Margin 2.5% 4.6% 5.3% 3.3% Normalized PAT* 393 327 20.0 179 63 183.1 *Adjusted for one off impact fr
Slide 13: Healthcare Retail
Healthcare Retail 23 Outlets existing outlets in Colombo, including 11 express outlets Highlights • Continued focus on Beauty and Wellness sales helped margin expansion • Thimbirigasyaya store opened in 4Q • Flagship store at Dharmapala Mw expanded • Consumer spending remains sluggish
Slide 14: FMCG
FMCG Growth 4Q 4Q Growth LKRm FY17 FY16 % FY17 FY16 % Revenue 4,213 3,440 22.5 1,202 920 30.6 EBIT 303 469 (35.4) 22 88 (75.1) EBIT Margin 7.2% 13.6% 1.8% 9.5% PAT 275 423 (34.9) 26 80 (67.0) PAT Margin 6.5% 12.3% 2.2% 8.7% Highlights • FY17 Revenue growth driven by branded tea sales in Domestic mar
Slide 15: Agri
Agri Growth 4Q 4Q Growth LKRm FY17 FY16 % FY17 FY16 % Revenue 6,502 6,299 3.2 1,764 1,684 4.8 EBIT 1,494 669 123.3 311 103 n/a EBIT Margin 23.0% 10.6% 17.6% 6.1% PAT 1,226 518 136.7 212 79 n/a PAT Margin 18.9% 8.2% 12.0% 4.7% Highlights • Revenue growth in line with strategy of focusing on quality v
Slide 16: Other
Other Energy Packaging • Revenue of LKR 89m for • The packaging division FY17 against LKR 120m last reported revenues of LKR year due to change in 326m, down 10% YoY in weather patterns FY17 • LKR -35m loss for FY17 against LKR 32m PAT last • High tea prices affected tea year can segment sales. • Up
Slide 17: Outlook
Outlook
Slide 18: Outlook for 1Q FY18
Outlook for 1Q FY18 Healthcare Agri • Focus on volume growth in • Tea prices likely to be firm Pharma, despite margin challenges • Focus on quality teas and crop • Focus on medical devices • OP Crop growth in focus, • More Beauty and Wellness sales in decrease in selling price Healthguard • Feed cos
Slide 19: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php
Slide 20: Additional data for analysts
Additional data for analysts 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q LKR m FY14 FY14 FY14 FY14 FY15 FY15 FY15 FY15 FY16 FY16 FY16 FY17 FY17 FY17 FY17 FY17 Revenue 3,473 3,498 3,743 3,982 3,984 4,166 4,072 4,105 4,179 4,341 4,288 4,615 4,621 5,056 4,425 5,115 PAT 125 236 415 350 326 225 289 2